NEUROVATION LABS INC
Small molecule AMPA receptor modulators targeting specific brain circuits via TARP biology
- Sector
- Medtech
- Headquarters
- New York, NY
- Founded
- 2016
- Latest Form D
- $150K, Oct 2016
- Total capital
- $1.4M
- Federal grants
- $1.3M
- 2 awards · 2019–2022
- Rank in peer group#350 of 477
- Private capital raised
- $150K
- 1 Form D · last Oct 2016
- 120 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 2 pending · first 2022
- Rank in peer group#99 of 477
Capital timeline
Latest events
- Federal grantDefense · Phase II · Objective Biomedical Diagnostic For Assessing Traumatic Brain Injury (TBI) & Other Trauma-Related Mental Health Conditions$1.2M
- Federal grantDefense · Phase I · Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need$50K
- Private capital raisedForm D · SEC · 1st filing$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#99 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Jennifer Nicole PerusiniResearcherExecutive Officer, DirectorLinked by 2 patents · $1.3M in grants as PI
- Cameron Taylor BloomerExecutive Officer, DirectorNamed in SEC Form D filings
- Jeremy Taylor BloomerDirectorNamed in SEC Form D filings
- Michael Taylor FanselowDirectorNamed in SEC Form D filings
- Richard Peter ZemskyExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 5- GrantedCompositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED PtsdUSPTOUS 12,274,761
- GrantedCompositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED Post-traumatic Stress Disorder And Other Neurological DisordersUSPTOUS 11,439,715
- GrantedCompositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED PtsdUSPTOUS 11,224,668
Show all 5 patent records
- Compositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED PtsdApr 15, 2025 · US 12,274,761Granted
- Compositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED Post-traumatic Stress Disorder And Other Neurological DisordersSep 13, 2022 · US 11,439,715Granted
- Compositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED PtsdJan 18, 2022 · US 11,224,668Granted
- Compositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED Post-traumatic Stress Disorder And Other Neurological DisordersApplication PCTUS2018048250Pending
- Compositions And Methods To Detect GLUA1 In Brain And To Identify The Presence Of GLUA1-MEDIATED PtsdApplication PCTUS2017019638Pending
Related companies, and why
- CALLAHAN-YOUNG LLCSimilar federal contract value in Medtech · null in contracts
- Powti Innovations, Inc.Similar federal contract value in Medtech · null in contracts
- Black Light Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- Lunair Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Axiomed, LLCSimilar federal contract value in Medtech · null in contracts
- MICROVASCULAR THERAPEUTICS LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .